Key points are not available for this paper at this time.
In the future, SEER data can be used to monitor clinical outcomes in women diagnosed with different molecular subtypes of breast cancer for a large portion (approximately 28%) of the US population.
Building similarity graph...
Analyzing shared references across papers
Loading...
Howlader et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69d7af6eb1cb92dd1bb8bb27 — DOI: https://doi.org/10.1093/jnci/dju055
Nadia Howlader
Sean F. Altekruse
Christopher I. Li
JNCI Journal of the National Cancer Institute
University of Washington
National Cancer Institute
Fred Hutch Cancer Center
Building similarity graph...
Analyzing shared references across papers
Loading...